Evaluation of a diphenylphosphorylazide-crosslinked collagen membrane for guided bone regeneration in mandibular defects in rats.
In the present study, the potential of a diphenylphosphorylazide-crosslinked type I bovine collagen membrane was evaluated in the healing of mandibular bone defects applying the biological concept of guided bone regeneration. The experiment was carried out on 25 Wistar rats. After exposing the mandibular ramus bilaterally, 5 mm diameter full-thickness circular bone defects were surgically created. While the defect on one side was covered by the membrane (experimental), the defect on the other side was left uncovered (control) before closure of the overlying soft tissues. The rats were sacrificed in groups of 5 after 7, 15, 30, 90, and 180 days of healing. Although at early stages of healing similar amounts of bone formation were observed in the experimental and control defects, after 1 month of healing, most of the experimental defects were completely closed with new bone, while in the control defects, only limited amounts of new bone were observed at the rims and in the lingual aspect of the lesions. In the 90- and 180-day animals, all experimental defects were completely closed, while in the control defects, no statistically significant increase in bone regeneration was observed. The increase in percentage of bone regeneration in the experimental defects was statistically significant between the 15-day specimens as compared with the 7-day specimens (P < 0.01) and likewise between 30-day and 15-day specimens (P < 0.001). It can be concluded that a DPPA-crosslinked collagen membrane yields biocompatibility, ad hoc mechanical hindrance, and handling characteristics suitable for guided bone regeneration applications in this experimental model.
Zahedi
S
S
Department of Periodontology and Implantology, School of Dentistry, Sart Tilman University Hospital, University of Liège, Belgium. shahram.zahedi@skynet.be
Legrand
R
R
Brunel
G
G
Albert
A
A
Dewé
W
W
Coumans
B
B
Bernard
J P
JP
D016301:Alveolar Bone Loss / Q000601:surgery*; D000818:Animals; D001386:Azides / Q000737:chemistry; D001672:Biocompatible Materials / Q000737:chemistry / Q000627:therapeutic use; D001861:Bone Regeneration; D002417:Cattle; D003094:Collagen / Q000737:chemistry* / Q000627:therapeutic use; D003432:Cross-Linking Reagents; D016557:Guided Tissue Regeneration, Periodontal / Q000379:methods*; D008334:Mandible; D008567:Membranes, Artificial; D051381:Rats; D017208:Rats, Wistar
D001386:Azides; D001672:Biocompatible Materials; D003432:Cross-Linking Reagents; D008567:Membranes, Artificial; D003094:Collagen; C007523:diphenylphosphorazidate